If you are considering GLP-1 therapy with PlexusDx and wondering about adjunctive berberine use, discussing your genetic and biomarker context with your provider can support a more personalized conversation about whether combination therapy aligns with your metabolic health goals and risk profile
Research suggests that autoimmune thyroid disease may be associated with insulin resistance, dyslipidaemia, and cardiovascular risk factors
Body Pharm supplies the Cagrisema 12mg injection pen for UK-based non-clinical research, combining 6mg cagrilintide and 6mg semaglutide in a single multi-dose device with a dial-a-dose mechanism mapped to published Novo Nordisk titration steps of 0.25mg, 0.5mg, 0.75mg, 1mg and 2mg per API [1]
Potential Benefits May support medically supervised appetite management
GHK-Cu 100 mg Research Grade GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine : copper) widely studied in skin-remodeling, wound-repair, and tissue-regeneration research models